Research Reports

Healthcare

icon
icon
Home » Reports » Cloud Based Drug Discovery Platform Market
Market Research Report

Cloud Based Drug Discovery Platform Market Segmentation By Type ( PaaS (Platform as a Service), SaaS (Software as a Service) and IaaS (Infrastructure as a Service)); By Application (Pharmaceutical Companies, Hospitals, Biotech Vendors and Contract Research Organizations) - Global Demand Analysis & Opportunity Outlook 2027

Published On : December, 2018 REP-ID-1123 Category: Healthcare

Product Overview

Drug discovery platform is a research and development platform where medicines are discovered and are formulated. In recent years, the drug discovery platform is observing great adoption of digital technologies. For instance, some key players are storing large data in cost effective manner in the cloud based drug discovery platforms. This platform enables many customers to overcome different challenges by establishing a network of web and mobile accessible applications. It enables secure and collaborative project management and the capability to share project information.

Market Size and Forecast

The global cloud based drug discovery platform market was valued around USD 4.5 Billion by the end of 2027. The CAGR of global cloud based drug discovery platform market is around 13.5% during 2017-2027. The increasing market growth can be attributed to increase in the implementation of cloud-based platforms in various application segments. Rise in adoption of cloud based mobile applications for various drug discoveries is also a reason for the expansion of the market size.

The global cloud based drug discovery platform market can be segmented on the basis of type and application. On the basis of application, it is further segmented into pharmaceutical companies, hospitals, biotech vendors and contract research organizations. The pharmaceutical sub-segment is the leading end-user segment in the global cloud based drug discovery platform market. The constant rise in demand of drug from the various pharmaceutical companies is expected to drive the market growth of the cloud based drug discovery platform.

By region, the global cloud based drug discovery platform market is segmented into North America, Asia-Pacific, Latin America, Europe, Middle East and Africa. North America is anticipated to lead the global cloud based drug discovery platform market on the account of easy availability of cloud platforms which support different enterprises to collect real-time data across the globe. These types of platforms deliver better access to data during the research and development process. Pharmaceutical and biotech vendors in North America are developing new technologies in order to enhancing drug development process by deploying cloud platforms.

Market Segmentation

Our in-depth analysis segmented the global cloud based drug discovery platform market in the following segments:

By Type

  • PaaS (Platform as a Service)
  • SaaS (Software as a Service)
  • IaaS (Infrastructure as a Service)

By Application

  • Pharmaceutical Companies
  • Hospitals
  • Biotech Vendors
  • Contract Research Organizations

By Region

The global cloud based drug discovery platform market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Turkey Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of Asia) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (GCC, Israel, North Africa, South Africa, Rest of Middle East) Market size, Y-O-Y growth & Opportunity Analysis.

Cloud Based Drug Discovery Platform Market Graph

Growth Drivers and Challenges

The various growth drivers associated with the global cloud based drug discovery market are increasing implementation of cloud-based platforms in the healthcare industry in order to improve research efficiency. The various developing technology such as machine learning and artificial intelligence enable better discovery and formulation of drug around the globe. The various regional healthcare companies are collaborating with the international healthcare market players in order to adopt cloud based technologies which will enable better discovery and identification of diseases. Cloud-based drug discovery platform can be accessed by many devices such as computers, notebook, and mobiles.

Various issues related to correlation of applications with devices are expected to hamper the market of cloud based drug discovery platform.

Key Players

  • IBM Corp,
  • Accenture PLC
  • BioXcel Corporation
  • Cloud Pharmaceuticals, Inc.
  • WuXi AppTec (Shanghai) Co., Ltd.
  • Dassault Systemes
  • BIOVIA Ltd.

things to know

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

RELATED REPORTS

Delivery Center

Ansal Corporate Park, Plot no 7A/1,
Tower A1,
Sector 142 Noida., 201301 India
info@researchnester.com

US Office

77 Water Street 8th Floor,
New York, New York, 10005
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com


UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Subscribe To Our Newsletters

Copyright © 2018 Research Nester. All rights reserved

Top